These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26470029)

  • 1. A Nano-MgO and Ionic Liquid-Catalyzed 'Green' Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51).
    Anusha S; Cp B; Mohan CD; Mathai J; Rangappa S; Mohan S; Chandra ; Paricharak S; Mervin L; Fuchs JE; M M; Bender A; Basappa ; Rangappa KS
    PLoS One; 2015; 10(10):e0139798. PubMed ID: 26470029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of antitubercular activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
    Kolavi G; Hegde V; Khazi Ia; Gadad P
    Bioorg Med Chem; 2006 May; 14(9):3069-80. PubMed ID: 16406644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
    Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives.
    Gadad AK; Noolvi MN; Karpoormath RV
    Bioorg Med Chem; 2004 Nov; 12(21):5651-9. PubMed ID: 15465343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
    Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
    Patel SR; Gangwal R; Sangamwar AT; Jain R
    Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
    Chitra S; Paul N; Muthusubramanian S; Manisankar P; Yogeeswari P; Sriram D
    Eur J Med Chem; 2011 Oct; 46(10):4897-903. PubMed ID: 21855182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
    Mahajan NS; Dhawale SC
    Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
    Nayyar A; Monga V; Malde A; Coutinho E; Jain R
    Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antituberculosis agents, I: Synthesis and antituberculosis activity of 2-aryl-1,3,4-thiadiazole derivatives.
    Foroumadi A; Mirzaei M; Shafiee A
    Pharmazie; 2001 Aug; 56(8):610-2. PubMed ID: 11534334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
    Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
    J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
    Ramprasad J; Nayak N; Dalimba U
    Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimycobacterial activity of azetidine-, quinazoline-, and triazolo-thiadiazole-containing pyrazines.
    Bonde CG; Peepliwal A; Gaikwad NJ
    Arch Pharm (Weinheim); 2010 Apr; 343(4):228-36. PubMed ID: 20205198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, evaluation and in silico molecular modeling of pyrroyl-1,3,4-thiadiazole inhibitors of InhA.
    Joshi SD; More UA; Koli D; Kulkarni MS; Nadagouda MN; Aminabhavi TM
    Bioorg Chem; 2015 Apr; 59():151-67. PubMed ID: 25800133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl alpha-(5-aryl-1, 3, 4-thiadiazole-2-ylthio)acetates.
    Foroumadi A; Soltani F; Moallemzadeh-Haghighi H; Shafiee A
    Arch Pharm (Weinheim); 2005 Mar; 338(2-3):112-6. PubMed ID: 15756694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
    Patel H; Jadhav H; Ansari I; Pawara R; Surana S
    Eur J Med Chem; 2019 Apr; 167():1-9. PubMed ID: 30743094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety.
    Güzeldemirci NU; Küçükbasmaci O
    Eur J Med Chem; 2010 Jan; 45(1):63-8. PubMed ID: 19939519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.